S.Amdt. 2011Senate117th Congress (2021-2023)2nd degree
S.Amdt. 2011
Sponsored by
Sen. Bill Hagerty (R-TN)
Submitted May 25, 2021
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
May 25, 2021
Text
Submitted
SA 2011. Mr. HAGERTY submitted an amendment intended to be proposed to amendment SA 1502 proposed by Mr. Schumer to the bill S. 1260, to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes; which was ordered to lie on the table; as follows: In section 3291I(c), strike ``a written report'' and all that follows through ``detailing a description'' and insert the following: ``an unclassified written report, with a classified annex, that includes-- (1) a description In section 3291I, amend subsection (e) to read as follows: [[Page S3452]] (e) Report on Drug Seizures.--Not later than 6 months after the date of the enactment of this Act, and annually thereafter, the Administrator of the Drug Enforcement Administration, in coordination with the Office of National Drug Control Policy, U.S. Customs and Border Protection, the Department of Homeland Security, the Department of Justice, the Coast Guard, the Centers for Disease Control and Prevention, the Office of the United States Trade Representative, the Office of the Director of National Intelligence, the Central Intelligence Agency , the Department of Defense, the United States Postal Service, and other relevant agencies, shall submit a report to Congress that describes-- (1) with respect to illicit fentanyl, fentanyl analogues, synthetic opioids, the precursors for illicit fentanyl, fentanyl analogues, or synthetic opioids, methamphetamine, or methamphetamine precursors seized at the United States borders and ports of entry-- (A) the source countries from which such drugs originated and the third party countries through which such drugs traveled; (B) the amounts of illicit fentanyl, fentanyl analogues, synthetic opioids, the precursors for illicit fentanyl, fentanyl analogues, or synthetic opioids, methamphetamine, or methamphetamine precursors; and (C) the lethality of the amounts of illicit fentanyl, fentanyl analogues, synthetic opioids, the precursors for illicit fentanyl, fentanyl analogues, or synthetic opioids, methamphetamine, or methamphetamine precursors seized; (2) with respect to illicit fentanyl, fentanyl analogues, synthetic opioids, the precursors for illicit fentanyl, fentanyl analogues, or synthetic opioids, methamphetamine, or methamphetamine precursors seized within the United States-- (A) the source countries from which such drugs originated and the third party countries through which such drugs traveled; (B) the amounts of illicit fentanyl, fentanyl analogues, synthetic opioids, the precursors for illicit fentanyl, fentanyl analogues, or synthetic opioids, methamphetamine, or methamphetamine precursors seized; and (C) the lethality of the amounts of illicit fentanyl, fentanyl analogues, synthetic opioids, the precursors for illicit fentanyl, fentanyl analogues, or synthetic opioids, methamphetamine, or methamphetamine precursors seized; and (3) the activities conducted by Chinese entities and nationals in furtherance of illicit fentanyl production in Mexico for drug trafficking purposes. ______